IN2015DN02514A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN02514A IN2015DN02514A IN2514DEN2015A IN2015DN02514A IN 2015DN02514 A IN2015DN02514 A IN 2015DN02514A IN 2514DEN2015 A IN2514DEN2015 A IN 2514DEN2015A IN 2015DN02514 A IN2015DN02514 A IN 2015DN02514A
- Authority
- IN
- India
- Prior art keywords
- alkyl group
- compound
- integer
- salt
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
Abstract
A compound which is a compound of formula (I) or any salt thereof: wherein R1 is a Ci- C6 alkyl group, R2 is H or a Ci- C6 alkyl group , R3 is H or a Ci- C6 alkyl group , and n is an integer from 0 to 5.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1215675.8A GB201215675D0 (en) | 2012-09-03 | 2012-09-03 | Compound |
| PCT/GB2013/052297 WO2014033477A1 (en) | 2012-09-03 | 2013-09-02 | Pyridinone compounds for use in photodynamic therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN02514A true IN2015DN02514A (en) | 2015-09-11 |
Family
ID=47075165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2514DEN2015 IN2015DN02514A (en) | 2012-09-03 | 2013-09-02 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9346758B2 (en) |
| EP (1) | EP2892881B1 (en) |
| JP (1) | JP2015526499A (en) |
| KR (1) | KR20150068374A (en) |
| CN (1) | CN104718190B (en) |
| AU (1) | AU2013308197B2 (en) |
| BR (1) | BR112015004732A2 (en) |
| CA (1) | CA2883754A1 (en) |
| GB (1) | GB201215675D0 (en) |
| IN (1) | IN2015DN02514A (en) |
| MX (1) | MX2015002705A (en) |
| RU (1) | RU2015111137A (en) |
| SG (1) | SG11201501604TA (en) |
| WO (1) | WO2014033477A1 (en) |
| ZA (1) | ZA201502153B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201215675D0 (en) | 2012-09-03 | 2012-10-17 | Univ Exeter | Compound |
| EP3148528A1 (en) | 2014-06-02 | 2017-04-05 | University of Exeter | Combinations of a photosensitizer with a hydrogen sulfide donor, thioredoxin inhibitor or nitroxide for use in photodynamic therapy |
| CN112062713B (en) * | 2020-08-04 | 2023-03-31 | 浙江工业大学 | ALA-HPO hybrid derivative with iron chelation and PDT activity and preparation method and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9217099D0 (en) * | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
| US5895786A (en) * | 1996-05-08 | 1999-04-20 | New York Blood Center, Inc. | Method for treating viral infections |
| GB0018528D0 (en) * | 2000-07-27 | 2000-09-13 | Photocure Asa | Compounds |
| GB201215675D0 (en) | 2012-09-03 | 2012-10-17 | Univ Exeter | Compound |
-
2012
- 2012-09-03 GB GBGB1215675.8A patent/GB201215675D0/en not_active Ceased
-
2013
- 2013-09-02 KR KR1020157008471A patent/KR20150068374A/en not_active Application Discontinuation
- 2013-09-02 CA CA2883754A patent/CA2883754A1/en not_active Abandoned
- 2013-09-02 IN IN2514DEN2015 patent/IN2015DN02514A/en unknown
- 2013-09-02 MX MX2015002705A patent/MX2015002705A/en unknown
- 2013-09-02 SG SG11201501604TA patent/SG11201501604TA/en unknown
- 2013-09-02 JP JP2015529127A patent/JP2015526499A/en active Pending
- 2013-09-02 US US14/425,385 patent/US9346758B2/en active Active
- 2013-09-02 BR BR112015004732A patent/BR112015004732A2/en not_active Application Discontinuation
- 2013-09-02 RU RU2015111137A patent/RU2015111137A/en not_active Application Discontinuation
- 2013-09-02 CN CN201380053228.0A patent/CN104718190B/en not_active Expired - Fee Related
- 2013-09-02 WO PCT/GB2013/052297 patent/WO2014033477A1/en active Application Filing
- 2013-09-02 AU AU2013308197A patent/AU2013308197B2/en not_active Ceased
- 2013-09-02 EP EP13771564.5A patent/EP2892881B1/en not_active Not-in-force
-
2015
- 2015-03-30 ZA ZA2015/02153A patent/ZA201502153B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201501604TA (en) | 2015-05-28 |
| JP2015526499A (en) | 2015-09-10 |
| CN104718190B (en) | 2017-03-08 |
| AU2013308197B2 (en) | 2018-02-01 |
| EP2892881A1 (en) | 2015-07-15 |
| RU2015111137A (en) | 2016-10-20 |
| ZA201502153B (en) | 2017-07-26 |
| MX2015002705A (en) | 2015-12-01 |
| WO2014033477A1 (en) | 2014-03-06 |
| CA2883754A1 (en) | 2014-03-06 |
| US9346758B2 (en) | 2016-05-24 |
| GB201215675D0 (en) | 2012-10-17 |
| US20150210642A1 (en) | 2015-07-30 |
| KR20150068374A (en) | 2015-06-19 |
| CN104718190A (en) | 2015-06-17 |
| BR112015004732A2 (en) | 2018-04-17 |
| AU2013308197A1 (en) | 2015-04-09 |
| EP2892881B1 (en) | 2017-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120188T1 (en) | NAPHYTHRIDINE PRODUCERS USEFUL AS INTEGRINE COMPONENTS avv6 | |
| IN2014MN02496A (en) | ||
| CR20130470A (en) | QUINASE INHIBITORS RELATED TO PIRROLO [2,3-d] PYRIMIDINE THROMPOMIOSINE | |
| JO3317B1 (en) | Tetrahydropyrrolothiazine compounds | |
| MY164776A (en) | Heterocyclic compound | |
| IN2013MN02014A (en) | ||
| UA111626C2 (en) | DIGIDROCHINOLIN-2-ON DERIVATIVES | |
| RS54730B1 (en) | Inhibitors of beta-secretase | |
| RS54526B1 (en) | Pyrazolospiroketone derivatives for use as acetyl-coa carboxylase inhibitors | |
| CO6821935A2 (en) | Novel cephalosporin derivatives and pharmaceutical cmpositions of these | |
| CR20140306A (en) | FLUORMETIL -5,6-DIHIDRO-4H- [1,3] OXAZINES | |
| TN2014000415A1 (en) | Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof | |
| MX2016007861A (en) | Dimethylbenzoic acid compounds. | |
| JO3318B1 (en) | Bace inhibitors | |
| JO3143B1 (en) | Tetrahydropyrrolothiazine compounds | |
| IN2015DN00446A (en) | ||
| GB2515909A (en) | Polymer | |
| UA113086C2 (en) | PRAZOLE COMPOUNDS AS SGLT1 INHIBITORS | |
| IN2014CN04449A (en) | ||
| IN2014DN06192A (en) | ||
| MY170262A (en) | Dicarboxylic acid compound | |
| MX369470B (en) | Means and method for treating solid tumours. | |
| IN2014DN07169A (en) | ||
| IN2015DN02514A (en) | ||
| EA201300794A1 (en) | NEW METHOD OF SYNTHESIS AGOMELATIN |